The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Treatment strategies that target the immune system provide the opportunity for antitumor activity across multiple cancer types, regardless of mutational status or tumor histology. While many of the initial advances in immunotherapy have been in melanoma, the focus has now broadened to include many other solid as well as hematological cancers. Different immunotherapeutic approaches are being evaluated...
Immuntherapien sind aufgrund der häufig geringen Tumorlast nach Primärtherapie und der fehlenden Kreuzresistenz zu etablierten Verfahren eine attraktive Option zur Verbesserung der Therapie gynäkologischer Malignome. Beispiele sind die Etablierung des monoklonalen Antikörpers Trastuzumab beim Mammakarzinom und die erfolgreiche HPV-basierte Impfung zur Prävention des Zervixkarzinoms. Dieser Beitrag...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.